Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXHITENTRE: Extended Release Buprenorphine vs Treatment as Usual for Hospitalized Patients With OUD
NCT04345718Phase 3Completed
- Start
- Aug 2021
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine in opioid use disorder (OUD). Started Aug 2021; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04345718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04345718.